7 insiders reported 12 Form 4 transactions for Kezar Life Sciences, Inc. (KZR) over the past 18 months (most recent 2026-05-11). Recent activity: BERGER FRANKLIN M (Director) Sell 89,069 shares, Schiller Mark C. (Chief Operating Officer) Sell 2,739 shares, Chiang Pichi Luo (SVP, Corporate Controller) Sell 2,711 shares, Kauffman Michael (Director) Sell 6,369 shares, Belsky Marc (Chief Financial Officer) Sell 1,538 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-11 | BERGER FRANKLIN M | Director | Sell | 89,069 | $0 |
| 2026-05-11 | Schiller Mark C. | Chief Operating Officer | Sell | 2,739 | $0 |
| 2026-05-11 | Chiang Pichi Luo | SVP, Corporate Controller | Sell | 2,711 | $0 |
| 2026-05-11 | Kauffman Michael | Director | Sell | 6,369 | $0 |
| 2026-05-11 | Belsky Marc | Chief Financial Officer | Sell | 1,538 | $0 |
| 2026-05-11 | Belsky Marc | Chief Financial Officer | Sell | 200 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 39,390 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 375 | $0 |
| 2026-05-11 | Fowler John Franklin | Director | Sell | 3,846 | $0 |
| 2026-05-11 | Kirk Christopher J. | CEO | Sell | 43,134 | $0 |
| 2025-07-03 | Schiller Mark C. | Chief Operating Officer | Sell | 561 | $2,401 |
| 2025-07-03 | Chiang Pichi Luo | SVP, Corporate Controller | Sell | 264 | $1,130 |
来源：SEC Form 4 申报文件 · 截至 2026-05-11